Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $299.47 | 20 | 87.0% |
| Education | $44.60 | 2 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $118.45 | 9 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $81.92 | 4 | $0 (2023) |
| Genentech USA, Inc. | $62.69 | 4 | $0 (2019) |
| GENZYME CORPORATION | $32.13 | 2 | $0 (2018) |
| Foundation Medicine, Inc. | $30.34 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $18.54 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $22.03 | 1 | Pharmacyclics LLC, An AbbVie Company ($22.03) |
| 2022 | $44.60 | 2 | PFIZER INC. ($44.60) |
| 2019 | $58.35 | 4 | PFIZER INC. ($29.70) |
| 2018 | $182.74 | 12 | Pharmacyclics LLC, An AbbVie Company ($40.63) |
| 2017 | $36.35 | 3 | Pharmacyclics LLC, An AbbVie Company ($19.26) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2019 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2019 | PFIZER INC. | SUTENT (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 02/26/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: BioOncology | ||||||
| 01/10/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: BioOncology | ||||||
| 12/11/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: BioOncology | ||||||
| 09/13/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2018 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2018 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2018 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: BioOncology | ||||||
| 03/30/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Oncology | ||||||
| 03/15/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Oncology | ||||||
| 01/16/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Oncology | ||||||
| 07/25/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Dr. Vikki Canfield, M.D
Dr. Vikki Canfield, M.D is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659322378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikki Canfield, M.D has received a total of $344.07 in payments from pharmaceutical and medical device companies, with $22.03 received in 2023. These payments were reported across 22 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($299.47).
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 05/15/2006
- Last Updated 04/22/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659322378
Products in Payments
- IBRANCE (Drug) $100.73
- Imbruvica (Drug) $59.89
- TECENTRIQ (Biological) $34.05
- JEVTANA (Drug) $32.13
- FOUNDATIONONE (Device) $30.34
- IMBRUVICA (Drug) $22.03
- XTANDI (Drug) $18.54
- Herceptin (Biological) $16.37
- SUTENT (Drug) $13.35
- VENCLEXTA (Biological) $12.27
- ELIQUIS (Drug) $4.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791